February 27, 2020 / 7:56 PM / a month ago

BRIEF-Generex Biotechnology Receives Contract From Chinese Partners To Develop Covid-19 Vaccine Using Ii-Key Peptide Vaccines

Feb 27 (Reuters) - Generex Biotechnology Corp:

* GENEREX BIOTECHNOLOGY - RECEIVES CONTRACT FROM CHINESE PARTNERS TO DEVELOP A COVID-19 VACCINE USING II-KEY PEPTIDE VACCINES

* GENEREX BIOTECHNOLOGY- TERMS APPROVED TO PROCEED WITH COLLABORATIVE EFFORT WITH INTERNATIONAL CONSORTIUM

* GENEREX BIOTECHNOLOGY - TERMS OF CONTRACT INCLUDE $1 MILLION UPFRONT PAYMENT TO INITIATE PROJECT WORK IN U.S. ,$5 MILLION LICENSING FEE FOR II-KEY TECHNOLOGY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below